20
Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Hyoscine hydrobromide, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2000-064 - Rev 01
This Chemical Type CEP, issued on September 09, 2008, remains in force until March 05, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 106 associated with this CEP further emphasizes